Boston Partners’s MaxLinear MXL Stock Holding History

Boston Partners’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-79,437	Closed	-$927K	–	685
2020 Q1	$927K	Buy	+79,437	New	+$1.33M	﹤0.01%	524

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Boston Partners's MXL Position: Q2 2020 in Review

Boston Partners sold out of MaxLinear (MXL) in Q2 2020, closing a stake of 79,437 shares — an estimated $927K sold.

Boston Partners first reported a position in MXL in Q1 2020 and held it in 1 quarter. The position peaked at $927K in Q1 2020. 163 funds tracked by Wall St. Rank hold MXL as of Q2 2020.

Boston Partners reported no remaining MaxLinear position as of Q2 2020 after selling out during the quarter.
Boston Partners sold 79,437 MaxLinear shares in Q2 2020, an estimated $927K.
Boston Partners first reported a position in MaxLinear in Q1 2020 and held it in 1 quarter.
Boston Partners's MaxLinear position peaked at $927K in Q1 2020.
163 funds tracked by Wall St. Rank held MaxLinear as of Q2 2020.

Based on Boston Partners's 13F filing for Q2 2020, filed 12 Aug 2020.